Brief: Zelira Therapeutics Launches Zyraydi B2b Technology To Create Pharma-Grade Cannabis Capsules & Tablets For Global Markets
20/09/2022 14:35
Sept 20 (Reuters) - Zelira Therapeutics Ltd ZLD.AX :
* ZELIRA THERAPEUTICS LAUNCHES ZYRAYDI™ B2B TECHNOLOGY TO
CREATE
PHARMA-GRADE CANNABIS CAPSULES & TABLETS FOR GLOBAL MARKETS
Source text for Eikon: ID:nPn3L8YwYa
Further company coverage: ZLD.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zelira Therapeutics
See all newsBrief: Zelira Therapeutics Announces $33 MLN Fundraising Into Zeliras HOPE 1 SPV
Australia's Zelira Therapeutics surges on $33 million funding for drug trial
Australia's Zelira Therapeutics climbs to over 7-month high on securing patents
Brief: Zelira Therapeutics Receives USD$1.4 Million Unsecured Loan Funds From Chairman
Brief: Zelira Therapeutics Ltd Says Zld Secures Us$1.4M Unsecured Chairman Loan Facility